Leprosy: an urgent need to step up use of MDT in Africa.
Mcdougall
A C
AC
D000293:Adolescent; D000349:Africa; D017954:Africa South of the Sahara; D000354:Africa, Western; D000367:Age Factors; D000900:Anti-Bacterial Agents; D001208:Asia; D001695:Biology; D002648:Child; D003710:Demography; D003906:Developing Countries; D003933:Diagnosis; D004194:Disease; D005069:Evaluation Studies as Topic; D007194:India; D007239:Infections; D007390:International Agencies; D008403:Mass Screening; D009461:Neurologic Manifestations; D009549:Nigeria; D009938:Organizations; D004364:Pharmaceutical Preparations; D010808:Physical Examination; D010827:Physiology; D011153:Population; D011154:Population Characteristics; D012867:Skin; D013812:Therapeutics; D014480:United Nations; D014944:World Health Organization
D000900:Anti-Bacterial Agents; D004364:Pharmaceutical Preparations
Africa; Africa South Of The Sahara; Age Factors; Antibiotics; Asia; Bacterial And Fungal Diseases--etiology; Biology; Child; Critique; Demographic Factors; Dermatological Effects; Developing Countries; Diseases; Drugs; English Speaking Africa; Examinations And Diagnoses; India; Infections; International Agencies; Neurologic Effects; Nigeria; Organizations; Physical Examinations And Diagnoses; Physiology; Population; Population Characteristics; Screening; Southern Asia; Treatment; Un; Western Africa; Who; Youth